Dr. Cortes Discusses Approval of Ponatinib for Adults with Chronic-phase CML

Jorge Cortes, MD, Director of the Georgia Cancer Center, talks about the approval of ponatinib for adults with chronic-phase chronic myeloid leukemia (CML), and why it’s important to continue research into ponatinib for chronic-phase CML. DocWire News: Can you discuss the study or studies that led to the supplemental new drug application for ponatinib for … Continue reading Dr. Cortes Discusses Approval of Ponatinib for Adults with Chronic-phase CML